LA
Therapeutic Areas
Arbutus Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Imdusiran (AB-729) | Chronic Hepatitis B (cHBV) | Phase 2 |
| AB-101 | Chronic Hepatitis B (cHBV) | Phase 2 |
| Combination Regimens (Imdusiran-based) | Chronic Hepatitis B (cHBV) | Phase 2 |
| AB-161 | Chronic Hepatitis B (cHBV) | Phase 1 |